Core Viewpoint - The management of Kaipu Testing has executed multiple share reduction plans amid a challenging performance environment, raising questions about the company's future outlook and management's confidence in its prospects [1][12]. Group 1: Management Share Reductions - In the second half of 2025, the chairman, general manager, board secretary, and three vice presidents of Kaipu Testing completed a share reduction plan, with ongoing plans for further reductions by the chairman and general manager [1]. - On January 26, 2026, Kaipu Testing announced that Chairman Yao Zhiqing plans to reduce his holdings by up to 3.12 million shares (3% of total shares), while Vice General Manager Song Xia plans to reduce up to 224,000 shares (0.2154% of total shares) [1][2]. - As of January 27, 2026, Kaipu Testing's market value was less than 2.5 billion yuan, with a closing price of 23.72 yuan per share, indicating that the combined cash from the planned reductions could exceed 79 million yuan [2]. Group 2: Recent Performance - In the first three quarters of 2025, Kaipu Testing's revenue growth was significantly pressured, with a year-on-year increase of only 0.17%, and a net profit of 57.84 million yuan, reflecting a 3.34% increase [12]. - The management's collective share reduction raises concerns about their confidence in the company's future performance, as they have not responded to inquiries regarding this matter [12]. Group 3: Historical Share Reductions - From October 29 to December 3, 2025, Yao Zhiqing reduced approximately 1.03 million shares at an average price between 22.26 and 24.05 yuan, cashing out over 22.99 million yuan [3][4]. - During the same period, Song Xia reduced 298,000 shares at an average price between 21.51 and 22.80 yuan, resulting in over 6.4 million yuan in cash [5][6]. - Other executives, including the board secretary Zhang Ran and Vice General Manager He Chun, also executed share reductions, with Zhang cashing out over 3.6 million yuan and He Chun over 8 million yuan [5][9].
董事长、总经理、董秘和副总经理“组团”减持!开普检测业绩增长承压